Premium
IMPACT OF CLASS II HLA MISMATCH ON CLINICAL OUTCOMES IN HODGKIN LYMPHOMA PATIENTS RECEIVING HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO‐SCT) WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE (PT‐CY)
Author(s) -
Castagna L.,
Bramanti S.,
Devillier R.,
Pagliardini T.,
Sarina B.,
Lemarie C.,
Furst S.,
Mariotti J.,
Granata A.,
Philippis C.,
Harbi S.,
Legrand F.,
Maisano V.,
Bouabdallah R.,
CarloStella C.,
Calmels B.,
Chaban C.,
Blaise D.,
Santoro A.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.109_2630
Subject(s) - human leukocyte antigen , medicine , cyclophosphamide , tacrolimus , lymphoma , immunology , transplantation , graft versus host disease , antigen , oncology , chemotherapy